Physician profile
Nathaniel M Ivanick
NPI 1063623098
$7,195.44
in general payments reported to CMS, 2019-2025
12 companies · $1,698 in 2025
The $1,698 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,617 · 2020: $129 · 2021: $135 · 2023: $272 · 2024: $345 · 2025: $1,698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,158 · Food and Beverage: $1,092 · Education: $64.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,157.99 |
| Food and Beverage | $1,091.83 |
| Education | $64.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $4,285.58 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Noah Medical Corporation | $1,663.36 | 2023-2025 | Galaxy |
| Intuitive Surgical, INC. | $301.06 | 2019 | |
| Boston Scientific Corporation | $178.23 | 2019 | |
| Serpex Medical INC | $172.43 | 2025 | |
| Erbe USA INC | $167.00 | 2025 | Cryo |
| Pinnacle Biologics, INC | $133.83 | 2021-2025 | Photofrin |
| Olympus America INC. | $109.77 | 2023 | Spiration Valve System |
| Ethicon INC. | $104.75 | 2020 | |
| Insmed, INC. | $64.96 | 2023-2024 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $14.47 | 2024 | Tezspire |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Ivanick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.